Investment
Features
FeesSafety
Academy
More
Pluang+

Gold faces pressure from rising yields and a strong dollar, with ETF demand its main support.

Market News
29 Sep 2026
Kitco
View Source
Bearish
Gold faces pressure from rising yields and a strong dollar, with ETF demand its main support.

Gold prices are under significant pressure due to a break below $4,230, rising U.S. Treasury yields, and a stronger dollar, which have triggered renewed selling. Despite these headwinds, gold ETF holdings continue to recover, suggesting some investor demand remains, especially from those less sensitive to interest rates. However, rising bond yields increase fiscal and refinancing risks, potentially causing short-term liquidity-driven selling of gold. This creates a paradox where higher yields may boost gold's long-term appeal as a safe asset, but also pressure prices in the near term. Investors will closely watch ETF flows to gauge gold's resilience amid these financial stresses.

Gold prices face pressure amid rising U.S. Treasury yields and a stronger dollar. For readers following Pluang's market, as of Sep 30, 2026 02:21 WIB, 66 of 150 US stocks rose while 82 fell. Notable movers include GFI at USD 37.01 (+5.20%, 48 days hold, 52% sell / 48% buy), PTON at USD 5.06 (+5.42%, 37 days hold), and FCEL at USD 16.95 (+5.02%, 48 days hold, 90% sell / 10% buy).

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
23 minutes ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
2 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
3 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
3 hours ago
Silver Elephant Mining ups private placement to raise CAD 882K for working capital.

Silver Elephant Mining ups private placement to raise CAD 882K for working capital.

Silver Elephant Mining Corp. has increased its non-brokered private placement to 7.35 million units at CAD 0.12 each, aiming to raise up to CAD 882,000. Each unit includes one common share and one warrant to buy an additional share at CAD 0.16 within...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App